These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38979294)

  • 1. A machine learning and drug repurposing approach to target ferroptosis in colorectal cancer stratified by sex and KRAS.
    Yan H; Shen X; Yao Y; Khan SA; Ma S; Johnson CH
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations.
    Yan H; Talty R; Jain A; Cai Y; Zheng J; Shen X; Muca E; Paty PB; Bosenberg MW; Khan SA; Johnson CH
    Redox Biol; 2023 Jun; 62():102699. PubMed ID: 37086630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations.
    Yan H; Talty R; Jain A; Cai Y; Zheng J; Shen X; Muca E; Paty PB; Bosenberg MW; Khan SA; Johnson CH
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer.
    Liu R; Wang Y; Bu J; Li Q; Chen F; Zhu M; Chi H; Yu G; Zhu T; Zhu X; Zhao G
    Int J Med Sci; 2024; 21(6):1103-1116. PubMed ID: 38774759
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
    Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
    Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erianin inhibits the growth and metastasis through autophagy-dependent ferroptosis in KRAS
    Miao Q; Deng WQ; Lyu WY; Sun ZT; Fan SR; Qi M; Qiu SH; Zhu YR; Lin JP; Chen MF; Deng LJ
    Free Radic Biol Med; 2023 Aug; 204():301-312. PubMed ID: 37217090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
    Xu QT; Qiang JK; Huang ZY; Jiang WJ; Cui XM; Hu RH; Wang T; Yi XL; Li JY; Yu Z; Zhang S; Du T; Liu J; Jiang XH
    Environ Toxicol; 2024 May; 39(5):2908-2926. PubMed ID: 38299230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets.
    Wang Y; Zhang Z; Sun W; Zhang J; Xu Q; Zhou X; Mao L
    Biomed Pharmacother; 2022 Sep; 153():113524. PubMed ID: 36076606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling.
    Zhou X; Kang J; Zhang L; Cheng Y
    Cancer Chemother Pharmacol; 2023 Aug; 92(2):119-134. PubMed ID: 37318525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.
    Firouzjaei AA; Aghaee-Bakhtiari SH; Tafti A; Sharifi K; Abadi MHJN; Rezaei S; Mohammadi-Yeganeh S
    Cell Biochem Funct; 2023 Dec; 41(8):1488-1502. PubMed ID: 38014635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.
    Huang Z; Huang X; Huang Y; Liang K; Chen L; Zhong C; Chen Y; Chen C; Wang Z; He F; Qin M; Long C; Tang B; Huang Y; Wu Y; Mo X; Weizhong T; Liu J
    Microbiol Spectr; 2024 May; 12(5):e0272023. PubMed ID: 38572984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in colorectal cancer: a future target?
    Yan H; Talty R; Aladelokun O; Bosenberg M; Johnson CH
    Br J Cancer; 2023 Apr; 128(8):1439-1451. PubMed ID: 36703079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
    Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
    Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
    Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.
    Liu P; Jiao F; Zhang Z; Zhao F; Cai J; Chen S; Fu T; Li M
    Am J Cancer Res; 2022; 12(11):5300-5314. PubMed ID: 36504908
    [No Abstract]   [Full Text] [Related]  

  • 20. AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation.
    Wang L; Lv C; Liu X
    Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38890190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.